You searched for "legislation"
CHEC treats first surgical eye patients at Stockport Exchange
Community healthcare provider restores sight for local residents in partnership with the NHS.
RTP801 as a neuroprotective and axon regenerative treatment
This paper describes the neuroprotective and axon regenerative effects of siRTP801, which is a translatable small-interfering RNA (siRNA) targeting mTOR negative regulator; RTP801, through in-vivo and in-vitro models. In-vivo studies involved an optic nerve crush rat model with intravitreal injections...A Shared Vision: national clinical director outlines plan for eye care transformation
This session will explore how nationally coordinated eye care can deliver improvements to patient outcomes, what should be the priorities and where responsibility for policy delivery sits across the NHS architecture. Attendees will have the opportunity to both learn more about NHS England’s ongoing work to support improvements to eye care and input into that process.
Undetected retinoblastoma management following vitrectomy
This retrospective study from a single-centre referral university hospital in Germany analysed data collected between 1991-2019 to comment on management and complications of undetected retinoblastoma eyes following vitrectomy. The 10 patients included had a mean age of 36.1 months (range...Scottish Government announces permanent free rail travel for companions of visually impaired people
Sight Scotland and Sight Scotland Veterans welcome the Scottish Government announcement today that free rail travel for companions of visually impaired people has been made a permanent policy across all ScotRail and Caledonian Sleeper services. Sight Scotland and Sight Scotland...What's trending Dec/Jan 2020
#eyedoctor #banned #visamix-up #HomeOffice #hostileenvironment An ophthalmologist was left stranded overseas when the Home Office refused him entry due to a visa mix-up. Dr Chan was working as a fellow at Moorfields Eye Hospital until August 2019, then was offered...Semaglutide and vision loss: A new concern for NAION risk?
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...Uveal melanoma
Uveal melanoma is the most common primary intraocular tumour. However, they are still rare, with an incidence of 2-8 per million [1]. The presence of a choroidal naevus is a risk factor for uveal melanoma [1]. Patients with choroidal lesions...Update on emerging therapies for age-related macular degeneration
The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...Treatment of diabetic macular oedema
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...Ophthalmic history made easy
There are now three ophthalmic medical documentaries to dip into on to Royal College of Ophthalmologists website.
